Surrozen, Inc. (SRZN) vs Turn Therapeutics Inc. (TTRX)

Surrozen, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Surrozen, Inc. and Turn Therapeutics Inc. are of similar size ($395.0M and $386.6M). Turn Therapeutics Inc. has the higher net margin (0.00% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Turn Therapeutics Inc. leads on 7 and Surrozen, Inc. on 4.

Valuation

Metric SRZN TTRX Biotechnology median
P/E n/m n/m 7.88
P/S 29.93 n/m 11.47
P/B n/m 533.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 21.07 n/m 10.73
Earnings yield (126.57%) (2.36%) (28.84%)
Free cash flow yield (10.15%) (1.22%) (23.03%)

Profitability

Metric SRZN TTRX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (385.28%) 0.00% 0.00%
Net margin (2,887.07%) 0.00% 0.00%
Free cash flow margin (303.92%) 0.00% 0.00%
Return on equity 387.44% (3,315.33%) (57.72%)
Return on assets (304.47%) (99.59%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SRZN TTRX Biotechnology median
Revenue growth (TTM) (8.79%) — 5.64%
EPS growth (last fiscal year) (49.38%) (80.72%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SRZN TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 12.14 1.19 4.73
Net debt to EBITDA 2.15 0.96 0.96

Dividend

Metric SRZN TTRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric SRZN TTRX Biotechnology median
Market cap 386.57m 394.99m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack